IP Library Granted Patent US 6,875,191
Granted Patent B2
US 6,875,191 · App. 09/976,832 · Granted Apr 5, 2005

Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,875,191
App. No.
09/976,832
Granted
Apr 5, 2005
Kind
B2
Abstract

Blood processing systems and methods convey blood cells from a blood cell source into a blood component collection flow channel that includes a blood cell storage container and an in-line filter to remove leukocytes from blood cells before entering the blood cell storage container. The systems and methods also convey additive solution from an additive solution source into the blood component collection flow channel. The systems and methods alternate the conveyance of blood cells through the filter with the conveyance of additive solution through the filter.

Claims (12)

1. A blood processing method comprising the steps of

(a) conveying blood cells from a blood cell source into a blood component collection flow channel that includes a blood cell storage container and an in-line filter to remove leukocytes from blood cells before entering the blood cell storage container,

(b) conveying additive solution from an additive solution source into the blood component collection flow channel, and

(c) repeatedly alternating steps (a) and (b) according to a pre-established pumping sequence to mix the additive solution with the blood cells at a substantially constant ratio.

2. A method according to claim 1

further including a step (d) comprising terminating step (a) when a desired volume of blood cells has been conveyed from the blood cell source and performing step (b) to flush residual blood cells from the filter into the blood cell storage container.

3. A method according to claim 1

further including a step of holding the filter in a restraining fixture during steps (a) and (b).

4. A method according to claim 1

further including a step of deriving a value reflecting volume of blood cells present in the blood cell collection container after passage through the filter as a percentage of volume of blood cells conveyed from the blood cell source to the filter.

5. A method according to claim 1

wherein the blood cells comprise red blood cells.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0549 →
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0597 →
SECOND-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 15, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019297/0168 →
FIRST-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019280/0211 →
PATENT ASSIGNMENT Recorded Apr 6, 2007
From: BAXTER INTERNATIONAL INC.
To: FENWAL, INC.
Reel/Frame 019129/0001 →